CSRTata Memorial study finds Nimotuzumab significantly increases survival in head and neck cancerNewsmantraJuly 31, 2024 by NewsmantraJuly 31, 20240 Tata Memorial study finds Nimotuzumab significantly increases survival in head and neck cancer...
